Published in Hepatitis Weekly, February 28th, 2000
Patients with an index value of 0.91 or less after undergoing a test to assess hepatic functional reserve seem to be the best candidates for this therapy, according to the researchers. The test, Technetium-99m diethylenetriamine pentaacetic acid-galactosyl human serum albumin (TC-GSA) liver scintigraphy, is used to calculate the index ratio of liver to heart-plus-liver 15 minutes after patient injection (LHL15). This index value of >0.91 is also used to determine whether surgery will be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.